Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020

SELL
$3.07 - $5.0 $75,101 - $122,315
-24,463 Closed
0 $0
Q2 2020

Aug 12, 2020

SELL
$2.06 - $3.76 $26,773 - $48,868
-12,997 Reduced 34.7%
24,463 $91,000
Q1 2020

May 12, 2020

BUY
$1.83 - $5.41 $34,413 - $101,735
18,805 Added 100.8%
37,460 $85,000
Q4 2019

Feb 11, 2020

BUY
$4.03 - $6.5 $75,179 - $121,257
18,655 New
18,655 $98,000

Others Institutions Holding GLYC

About GLYCOMIMETICS INC


  • Ticker GLYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,423,900
  • Market Cap $16.3M
  • Description
  • GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...
More about GLYC
Track This Portfolio

Track Spark Investment Management LLC Portfolio

Follow Spark Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spark Investment Management LLC with notifications on news.